Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract

A technology of chondroitin sulfate and composition, which is applied in the direction of drug combination, medical raw materials derived from ginkgo biloba, pill delivery, etc., and can solve problems such as undiscovered

Inactive Publication Date: 2011-04-20
菲伯纳生物医药有限责任公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Although the development of separate products of chondroitin sulfate and Ginkgo biloba extract emerges in endlessly, a pharmaceutical composition composed of chondroitin sulfate and / or its medicinal salt and Ginkgo biloba extract has not been found in many products. Compound composition, to fill its gap, expect to achieve a better effect of lowering blood fat and improving blood circulation, and research and development of a pharmaceutical composition composed of pectin sulfate and / or its medicinal salt and ginkgo biloba extract has become an urgent problem to be solved. The problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract
  • Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract
  • Medicinal composition consisting of chondroitin sulfate and/or medicinal salt thereof and ginkgo leaf extract

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0023] Formula of soft capsules (make 1000 capsules, each capsule contains 80mg of ginkgo biloba extract, 1mg of chondroitin sulfate)

[0024]

[0025] Preparation:

[0026] Mix the Ginkgo biloba extract and chondroitin sulfate in the above formula, add polyethylene glycol 400 and glycerin, stir evenly, pass through a colloid mill to make a suspension solution, and use gelatin-based soft capsules to make a uniform thickness The film is obtained by placing the medicinal solution in two films and pressing it into oval soft capsules.

example 2

[0028] Tablet formula (made into 1000 tablets, each containing 1 mg of ginkgo biloba extract and 600 mg of chondroitin sulfate sodium salt)

[0029]

[0030] Preparation:

[0031] Take all the ingredients of the above formula, except for magnesium stearate, mix the rest of the ingredients, use water or ethanol solution as a binder, granulate with a 14-mesh sieve, dry at 70-80°C, and granulate with a 12-mesh sieve , and then add magnesium stearate, mix well, and press into tablets.

example 3

[0033] The formula of granules (make 1000 bags, each bag contains 40mg of ginkgo biloba extract, 100mg of chondroitin sulfate)

[0034]

[0035] Preparation:

[0036] Take various substances of the above formula, use water or ethanol solution as binder, granulate with 14-mesh sieve, dry at 70-80°C, granulate with 12-mesh sieve, and pack into bags.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a medicinal composition consisting of chondroitin sulfate and / or medicinal salt thereof and ginkgo leaf extract. The medicinal composition is characterized in that: the medicinal composition is prepared by mixing the chondroitin sulfate and / or the medicinal salt thereof and the ginkgo leaf extract serving as active ingredients and pharmaceutically acceptable auxiliary materials, wherein the adding amount of the chondroitin sulfate and / or the medicinal salt thereof in the medicinal composition is 0.2 to 60 percent, the adding amount of the ginkgo leaf extract is 0.1 to 16 percent, and the adding amount of the pharmaceutically acceptable auxiliary materials is 39.9 to 99.7 percent. The medicinal composition can better treat the symptoms such as hyperlipidemia, hypercholesterolemia, coronary heart disease, arteriosclerosis, stenocardia, myocardial ischemia, myocardial infarction and the like, also can activate blood, dissolve stasis and dredge meridians, is used for chest numbness, cardiodynia, stroke, hemiplegia, tongue uncontrollability and unclear speech caused by blood stasis and meridian obstruction, and has no toxic or side effect.

Description

technical field [0001] The present invention relates to a medicinal composition, in particular to a medicinal composition for the treatment of hyperlipidemia, hypercholesterolemia, coronary heart disease, arteriosclerosis, angina pectoris, myocardial ischemia, myocardial infarction, etc. A medicinal composition containing chondroitin sulfate and / or its medicinal salt and ginkgo biloba extract for chest obstruction, heartache, stroke, hemiplegia, strong tongue and dysphagia caused by congestion and obstruction of collaterals, which belongs to the preparation of medicinal compositions technology field. Background technique [0002] Chondroitin Sulfate is a macromolecular acidic mucopolysaccharide prepared from the cartilage tissue of pigs, cattle, sheep and other animals and the cartilage of aquatic products such as sharks by using biochemical extraction technology. The sodium salt, potassium salt, calcium salt and zinc salt of chondroitin sulfate are widely used in medicine,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/16A61K9/48A61K9/20A61K9/16A61K47/34A61K47/36A61K47/38A61P3/06A61P9/10A61P7/02A61K31/737A61K127/00A61K47/10
Inventor 曾星
Owner 菲伯纳生物医药有限责任公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products